Drug Resistance Pattern of M. tuberculosis Complex in Oromia Region of Ethiopia

References

• World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2014.
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2019.
   Google Scholar
• Federal Ministry of Health. Guideline for Program and Clinical Management of Drug Resistant Tuberculosis. 2nd ed. Addis Ababa: FMoH; 2014.
   Google Scholar
• Federal Ministry of Health. National Guidelines for Management of Tuberculosis, Drug Resistant-Tuberculosis and Leprosy in Ethiopia. 6th ed. Addis Ababa, Ethiopia: FMoH; 2017.
   Google Scholar
• Canetti D, Riccardi N, Martini M, et al. HIV and tuberculosis: the paradox of dual illnesses and the challenges of their fighting in the history. Tuberculosis. 2020;122:101921. doi:10.1016/j.tube.2020.10192132501257
   PubMed Web of Science ®Google Scholar
• Martin A, Portaels F. Drug Resistance and Drug Resistance Detection, in Tuberculosis 2007 from Basic Science to Patient Care. 1st ed. Palomino JC, Leão SC, Ritacco V editors. Belgium, Brazil, Argentina: Bourcillierkamps.com; 2007:635–660.
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2011.
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2012.
   Google Scholar
• World Health Organization. Global tuberculosis report. Geneva. WHO.2013. Available from: http://www.who.int/iris/bitstream/10665/91355/1/9789241564656eng.pdf. Accessed 720, 2015.
   Google Scholar
• World Health Organization. Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: WHO; 2014b.
   Google Scholar
• World Health Organization. The end TB strategy: the essentials. Geneva: WHO; 2015. Available from:https://www.who.int/tb/publications/2015/end_tb_essential.pdf. Accessed 310, 2020.
   Google Scholar
• World Health Organization. Global tuberculosis report. Geneva: WHO; 2018. Available from: https://apps.who.int/iris/handle/10665/274453. Accessed 1126, 2019.
   Google Scholar
• Pang Y, Zhou Y, Zhao B, Liu G, Jiang G. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One. 2012;7(3):e32976. doi:10.1371/journal.pone.003297622412962
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Marker M. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infect Dis. 2013;13(1):131. doi:10.1186/1471-2334-13-13123496968
   PubMed Web of Science ®Google Scholar
• Federal Ministry of Health. Tuberculosis, Leprosy, and TB/HIV Prevention and Control Program Manual. 4th ed. Addis Ababa, Ethiopia: FMoH; 2008:30.
   Google Scholar
• Federal Democratic Republic of Ethiopia. The National Standard Operating Procedures for Biological Sample Transportation. Addis Ababa, Ethiopia: FDRE; 2014.
   Google Scholar
• World Health Organization. Laboratory Services in Tuberculosis Control: Microscopy Part II for the Global Tuberculosis Program. Geneva: WHO; 1998a.
   Google Scholar
• World Health Organization. Laboratory Services in Tuberculosis Control: Culture Part III. For the Global Tuberculosis Program. Geneva: WHO; 1998b.
   Google Scholar
• Tauns Laboratories, Inc. CapilaTM TB-Neo version 6.0. Available from: https://www.goffinmoleculartechnologies.com/wp-content/uploads/2018/11/IFU_capilia_tb-neo_packageinsert_c61.pdf. Accessed April 27, 2021.
   Google Scholar
• Hain-Lifescience GmbH. GenoType MTBDRplus 2.0 product. Available from: https://www.ghdonline.org/uploads/MTBDRplusV2_0212_304A-02-02.pdf. Accessed 331, 2019.
   Google Scholar
• Hain-Lifescience GmbH. GmbH GenoType MTBDRsl 2.0 product. Available from: https://www.immunodiagnostic.fi/wp-content/uploads/MTBDRsl-V2_kit-insert.pdf. Accessed 331, 2019.
   Google Scholar
• Tripathi R, Anupurba S. Multidrug - resistant tuberculosis detection and characterisation of mutations in Mycobacterium tuberculosis by genotype MTBDRplus. Indian J Pathol Microbiol. 2017;60(2):239–242. doi:10.4103/IJPM.IJPM_53_1628631643
   PubMed Web of Science ®Google Scholar
• Brhane M, Kebede A, Petros Y. Molecular detection of multidrug- resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia. Infect Drug Resist. 2017;10:75. doi:10.2147/IDR.S12790328331348
   PubMed Web of Science ®Google Scholar
• Tadesse M, Aragaw D, Dimah B, et al. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. Int J Mycobacteriol. 2016;5(2):85–191. doi:10.1016/j.ijmyco.2016.02.009
   Google Scholar
• Tamrat F. Molecular Epidemiology and Drug Sensitivity of Mycobacterium Tuberculosis Isolates among New Pulmonary Tuberculosis Patients in Arsi Zone Oromiya Region, Ethiopia (Doctoral dissertation). Addis Ababa University; 2016.
   Google Scholar
• Diriba G, Kebede A, Tola HH, et al. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia. Infect Dis Poverty. 2019;8(1):54. doi:10.1186/s40249-019-0554-431200748
   PubMed Web of Science ®Google Scholar
• Wondale B, Medhin G, Abebe G, et al. Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo zone, Southern Ethiopia. Infect Drug Resist. 2018;11:1581–1589. doi:10.2147/IDR.S16508830288068
   PubMed Web of Science ®Google Scholar
• Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. First- and second-line antituberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis. 2012;16(6):805–811. doi:10.5588/ijtld.11.052222390880
   PubMed Web of Science ®Google Scholar
• Yonge SA, Otieno MF, Sharma RR, Nteka SS. Drug susceptibility patterns of Mycobacterium tuberculosis isolates from tuberculosis patients in coastal Kenya. J Tuberc Res. 2017;5(4):201–219. doi:10.4236/jtr.2017.54022
   Google Scholar
• Sabeel S, Salih MA, Ali M, et al. Phenotypic and genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from sudanese patients. Tuberc Res Treat. 2017;2017:1–6. doi:10.1155/2017/8340746.
   Google Scholar
• Riccardi N, Alagna R, Saderi L, et al. Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference centres. BMC Infect Dis. 2019;19(1):1–9. doi:10.1186/s12879-019-4211-030606108
   PubMed Web of Science ®Google Scholar
• Riccardi N, Villa S, Alagna R, et al. Advantages and challenges of tailored regimens for drug-resistant tuberculosis: a stopTB Italia look into the future. Infect Drug Resist. 2020;13:2795–2800. doi:10.2147/IDR.S257480 PMID: 32848428; PMCID: PMC7429110.32848428
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guideline: Nutritional Care and Support for Patients with Tuberculosis. Geneva, Switzerland: WHO; 2013.
   Google Scholar
• Fletcher HA, Tanner R, Wallis RS, et al. Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG. Clin Vaccine Immunol. 2013;20(11):1683–1689. doi:10.1128/CVI.00427-1323986316
   PubMedGoogle Scholar
• Kashongwe IM, Mawete F, Mbulula L, et al. Outcomes and adverse events of pre-and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: a retrospective cohort study. PLoS One. 2020;15(8):e0236264. doi:10.1371/journal.pone.023626432750060
   PubMed Web of Science ®Google Scholar
• Villa S, Riccardi N, Canetti D, et al. From the past a long way to future Challenges for a great control of tuberculosis. Tuberculosis. 2020; 123:101948.32741532
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. PMID: 24141714. doi:10.1001/jama.2013.28105324141714
   PubMed Web of Science ®Google Scholar